Literature DB >> 6295365

Ecto-5'nucleotidase and adenosine deaminase activities of lymphoid cells.

J Dornand, J C Bonnafous, J Favero, J C Mani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6295365     DOI： 10.1016/0006-2944(82)90065-5

Source DB:  PubMed          Journal:  Biochem Med        ISSN： 0006-2944


× No keyword cloud information.
  7 in total

Review 1.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Elevated adenosine deaminase levels in celiac disease.

Authors:  Basak Cakal; Yavuz Beyazit; Seyfettin Koklu; Erdem Akbal; Ibrahim Biyikoglu; Gulsen Yilmaz
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  5-nucleotidase activity in cultured cell lines. Effect of different assay conditions and correlation with cell proliferation.

Authors:  J Turnay; N Olmo; G Risse; K von der Mark; M A Lizarbe
Journal:  In Vitro Cell Dev Biol       Date:  1989-11

4.  Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues.

Authors:  A Eroglu; O Canbolat; S Demirci; H Kocaoglu; Y Eryavuz; H Akgül
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

5.  Activities of adenosine deaminase, 5'-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues.

Authors:  O Canbolat; I Durak; R Cetin; M Kavutcu; S Demirci; S Oztürk
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors.

Authors:  J Dornand; M Gerber
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

7.  Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.

Authors:  R Huang; M Rosenbach; R Vaughn; D Provvedini; N Rebbe; S Hickman; J Goding; R Terkeltaub
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.